X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ALEMBIC PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS ALEMBIC PHARMA J.B.CHEMICALS/
ALEMBIC PHARMA
 
P/E (TTM) x 17.7 15.6 113.8% View Chart
P/BV x 2.2 3.4 65.9% View Chart
Dividend Yield % 0.5 1.1 46.8%  

Financials

 J.B.CHEMICALS   ALEMBIC PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
ALEMBIC PHARMA
Mar-19
J.B.CHEMICALS/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs363664 54.7%   
Low Rs255412 61.8%   
Sales per share (Unadj.) Rs169.1208.7 81.0%  
Earnings per share (Unadj.) Rs16.631.0 53.5%  
Cash flow per share (Unadj.) Rs23.437.1 63.1%  
Dividends per share (Unadj.) Rs2.005.50 36.4%  
Dividend yield (eoy) %0.61.0 63.3%  
Book value per share (Unadj.) Rs172.5144.2 119.6%  
Shares outstanding (eoy) m83.57188.52 44.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.82.6 70.9%   
Avg P/E ratio x18.617.4 107.2%  
P/CF ratio (eoy) x13.214.5 91.0%  
Price / Book Value ratio x1.83.7 48.0%  
Dividend payout %12.017.7 67.9%   
Avg Mkt Cap Rs m25,827101,461 25.5%   
No. of employees `0003.8NA-   
Total wages/salary Rs m2,5117,467 33.6%   
Avg. sales/employee Rs Th3,747.4NM-  
Avg. wages/employee Rs Th665.7NM-  
Avg. net profit/employee Rs Th367.8NM-  
INCOME DATA
Net Sales Rs m14,13539,347 35.9%  
Other income Rs m36694 390.0%   
Total revenues Rs m14,50139,441 36.8%   
Gross profit Rs m2,1788,736 24.9%  
Depreciation Rs m5701,152 49.4%   
Interest Rs m35184 19.0%   
Profit before tax Rs m1,9407,493 25.9%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5521,568 35.2%   
Profit after tax Rs m1,3875,844 23.7%  
Gross profit margin %15.422.2 69.4%  
Effective tax rate %28.520.9 136.1%   
Net profit margin %9.814.9 66.1%  
BALANCE SHEET DATA
Current assets Rs m10,47019,577 53.5%   
Current liabilities Rs m2,74914,896 18.5%   
Net working cap to sales %54.611.9 459.1%  
Current ratio x3.81.3 289.8%  
Inventory Days Days5590 61.5%  
Debtors Days Days7845 171.2%  
Net fixed assets Rs m5,81127,097 21.4%   
Share capital Rs m167377 44.3%   
"Free" reserves Rs m14,24826,811 53.1%   
Net worth Rs m14,41627,188 53.0%   
Long term debt Rs m04,993 0.0%   
Total assets Rs m17,64947,778 36.9%  
Interest coverage x56.641.7 135.7%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.80.8 97.3%   
Return on assets %8.112.6 63.9%  
Return on equity %9.621.5 44.8%  
Return on capital %13.723.6 58.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16419,453 31.7%   
Fx outflow Rs m1,3346,065 22.0%   
Net fx Rs m4,82913,388 36.1%   
CASH FLOW
From Operations Rs m1,2318,120 15.2%  
From Investments Rs m-208-7,556 2.8%  
From Financial Activity Rs m-595590 -100.8%  
Net Cashflow Rs m4271,153 37.0%  

Share Holding

Indian Promoters % 55.4 74.1 74.8%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 2.9 116.9%  
FIIs % 3.9 9.1 42.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 13.9 266.2%  
Shareholders   30,437 49,328 61.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 491 Points Lower; Metal and Energy Stocks Witness Selling(Closing)

After opening the day marginally lower, share markets in India witnessed negative trading activity throughout the day and ended deep in the red.

Related Views on News

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

FM Nirmala Sitharaman Inherits an Economy Facing a Number of Headwinds(Sector Info)

Jun 4, 2019

The Indian economy is in a major slowdown. Will the new finance minister, Nirmala Sitharaman bring the much-needed reforms?

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 17, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS